Composition
- Active ingredients
- CEFTAZIDIME 1GM/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEFTAZIDIME 2GM/VIAL · InjectableANDA062640-003 · Prescription
- CEFTAZIDIME 500MG/VIAL · InjectableANDA062640-001 · Discontinued
- CEFTAZIDIME 6GM/VIAL · InjectableANDA062640-004 · Prescription
- CEFTAZIDIME 1GM/VIAL · InjectableANDA062640-002 · Prescription
- CEFTAZIDIME 1GM/VIAL · InjectableThis page
- CEFTAZIDIME 2GM/VIAL · InjectableANDA065481-003 · Discontinued
- CEFTAZIDIME 500MG/VIAL · InjectableANDA065481-001 · Discontinued
- CEFTAZIDIME 1GM/VIAL · InjectableANDA065196-001 · Discontinued
- CEFTAZIDIME 6GM/VIAL · InjectableANDA065482-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA065481.
At a glance
- Brand name
- Ceftazidime
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Aurobindo Pharma LTD
- Status
- Discontinued
- FDA approval
- 28 May 2010
- Application
- ANDA065481-002